Bicarbonate-buffered handling medium
OtherThe investigators will evaluate whether the usual bicarbonate culture medium can replace the HEPES buffered medium effectively.
NCT Number: NCT03778866
The pH stability during human gamete handling for intracytoplasmic sperm injection (ICSI) is physiologically sound. As the pH change for bicarbonate-buffered medium, scientists assumed whether the use of HEPES or MOPS buffered medium would provide more stable pH, thereby better outcomes. However, the oil use and time frame outside the incubators have not been accounted for. This study is to evaluate the use of HEPES buffered medium compared with the bicarbonate-buffered medium on ICSI outcomes.
Looking for future studies?
Notify Me18 year–40 year
Female
Interventional
Not applicable
Qena Fertility Center, Qina, Qena Governorate, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The investigators will evaluate whether the usual bicarbonate culture medium can replace the HEPES buffered medium effectively.
Time frame: 40 weeks
viable neonate after 30 weeks of Gestation
Time frame: 12 weeks
a positive heartbeat on ultrasound at ≥ 7 weeks of gestation
Time frame: two weeks
positive b-hCG at ≥ 14 days following embryo transfer
Time frame: 6 days of culture
fertilized oocyte per injected ones and developed embryos per fertilized oocytes
Time frame: 16 weeks
Continued pregnancy after week 12 of gestation
Muhammad Fawzy
Other Gov
Whether the Use of HEPES-buffered Medium Would Affect Live Birth Rate After ICSI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06659692
Genital Diseases, Infertility
Toronto, Ontario, Canada
View Trial DetailsNCT06924437
Abnormal Uterine Bleeding (AUB), Endometrial Polyp
Sohag, Egypt
View Trial DetailsNCT01511588
Adolescents, Amenorrhea
Bethesda, Maryland, United States
View Trial DetailsNCT07399535
Adnexal Diseases, Cysts
Karachi, Sindh, Pakistan
View Trial Details